Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

QNCX Quince Therapeutics Inc

1,87

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:03:49

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Quince Therapeutics Charts.

News Quince Therapeutics Inc

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 27 Dezember 2024 (6 Tage vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 27 Dezember 2024 (6 Tage vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 18 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
Mittwoch 13 November 2024 (2 Monate vor) • Business Wire

Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research
Dienstag 12 November 2024 (2 Monate vor) • Business Wire

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting
Montag 11 November 2024 (2 Monate vor) • Business Wire

Quince Therapeutics to Participate at Upcoming Investor Conferences
Montag 14 Oktober 2024 (3 Monate vor) • Business Wire

Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Dienstag 3 September 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Quince Therapeutics Inc News-Artikel

Gold vs US Dollar

JP Morgan Chase

Euro vs Sterling

Deutsche Lufthansa

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen